Vantage Financial Partners (Illinois)’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
$296K Sell
535
-55
-9% -$31.5K 0.07% 94
2024
Q1
$343K Hold
590
0.09% 88
2023
Q4
$313K Sell
590
-65
-10% -$31.5K 0.1% 92
2023
Q3
$332K Buy
655
+100
+18% +$53.3K 0.19% 76
2023
Q2
$290K Hold
555
0.16% 82
2023
Q1
$320K Hold
555
0.19% 76
2022
Q4
$306K Sell
555
-50
-8% -$26.5K 0.18% 80
2022
Q3
$307K Sell
605
-300
-33% -$168K 0.2% 72
2022
Q2
$492K Buy
+905
New +$498K 0.29% 56

Other funds holding TMO

Vantage Financial Partners (Illinois)'s TMO Position: Q2 2024 in Review

Vantage Financial Partners (Illinois) reduced its Thermo Fisher Scientific (TMO) stake by 9.3% in Q2 2024, selling an estimated $31.5K and leaving 535 shares worth $296K. The position accounts for 0.07% of the portfolio, ranked #94.

Vantage Financial Partners (Illinois) first reported a position in TMO in Q2 2022 and has held it in 9 quarters since. The position peaked at $492K in Q2 2022. 2,544 funds tracked by Wall St. Rank hold TMO as of Q2 2024.

  • Vantage Financial Partners (Illinois) held 535 shares of Thermo Fisher Scientific worth $296K as of Q2 2024.
  • Vantage Financial Partners (Illinois) sold 55 Thermo Fisher Scientific shares in Q2 2024, an estimated $31.5K.
  • Thermo Fisher Scientific made up 0.07% of Vantage Financial Partners (Illinois)'s portfolio in Q2 2024, its #94 holding.
  • Vantage Financial Partners (Illinois) first reported a position in Thermo Fisher Scientific in Q2 2022 and has held it in 9 quarters since.
  • Vantage Financial Partners (Illinois)'s Thermo Fisher Scientific position peaked at $492K in Q2 2022.
  • 2,544 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2024.

Based on Vantage Financial Partners (Illinois)'s 13F filing for Q2 2024, filed 14 Aug 2024.